Funding, M&A, exec moves and hiring — matched to your market, with the people to call.See plans →
Nanjing Mumuxili raises tens of millions in Series B led by Huarui Group to enhance its microscopy tech. The funding will support growth through its subsidiary, Nanjing Kaishimai Technology.
PRIVATEAug 05, 2026•3 days ago
Amount Raised
$10 Million
Round Type
Series B
Nanjing CityManufacturingBiotechnologyInvestors
Jiangning Jingkai CapitalJushi CapitalZhongsheng YueshiHuarui Group
Description
Nanjing Mumuxili Technology said on August 4 it has closed a Series B round worth tens of millions of yuan. Huarui Group led the round, with Zhongsheng Yueshi, Jushi Capital, and Jiangning Jingkai Capital joining as co-investors. The funding flows through Mumuxili's wholly owned subsidiary, Nanjing Kaishimai Technology. Backing from a mix of corporate and local government-linked investors indicates strong interest in domestic precision-instrument startups.
Funding Insights
Based on industry dataTimeline to next round
Series B companies typically work for 15-20 months before raising new capital
Growth expectations
Series B companies are expected to scale rapidly and expand market reach
VC-backed spending patterns
VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech